CVS Health
CVS
1,573 hedge funds and large institutions have $84.3B invested in CVS Health in 2016 Q2 according to their latest regulatory filings, with 99 funds opening new positions, 672 increasing their positions, 654 reducing their positions, and 73 closing their positions.
36% more first-time investments, than exits
New positions opened: 99 | Existing positions closed: 73
23% more call options, than puts
Call options by funds: $562M | Put options by funds: $456M
3% more repeat investments, than reductions
Existing positions increased: 672 | Existing positions reduced: 654
1% more funds holding
Funds holding: 1,563 → 1,573 (+10)
2.12% less ownership
Funds ownership: 84.5% → 82.38% (-2.1%)
9% less capital invested
Capital invested by funds: $92.4B → $84.3B (-$8.07B)
26% less funds holding in top 10
Funds holding in top 10: 239 → 176 (-63)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$836M |
| 2 |
D.E. Shaw & Co
New York
|
+$537M |
| 3 |
Nordea Investment Management
Stockholm,
Sweden
|
+$441M |
| 4 |
Renaissance Technologies
New York
|
+$363M |
| 5 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
+$139M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal London Asset Management
United Kingdom
|
-$2.76B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$712M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$631M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$474M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$459M |
CVS Hedge Fund Activity: Q2 2016 in Review
1,573 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q2 2016, worth a combined $84.3B — down 8.7% from $92.4B a quarter earlier.
Buyers outnumbered sellers: 99 funds opened new CVS positions and 73 closed out — a net gain of 26 holders — while 672 added to existing stakes and 654 trimmed.
The largest buyer was Macquarie Group, adding an estimated $836M. The largest seller was Royal London Asset Management, cutting an estimated $2.76B.
- 1,573 institutional investors held CVS Health (CVS) as of Q2 2016, up from 1,563 in Q1 2016.
- Funds reported $84.3B of CVS Health stock for Q2 2016, down 8.7% quarter-over-quarter.
- 99 funds opened new CVS Health positions in Q2 2016 and 73 closed out, a net change of +26 holders.
- The largest CVS Health buyer in Q2 2016 was Macquarie Group, an estimated $836M added.
- The largest CVS Health seller in Q2 2016 was Royal London Asset Management, an estimated $2.76B sold.
Based on aggregated 13F filings for Q2 2016.